Sibilio, P.; Zizzari, I.G.; Gelibter, A.; Siringo, M.; Tuosto, L.; Pace, A.; Asquino, A.; Valentino, F.; Sabatini, A.; Petti, M.;
et al. Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study. Cancers 2025, 17, 922.
https://doi.org/10.3390/cancers17060922
AMA Style
Sibilio P, Zizzari IG, Gelibter A, Siringo M, Tuosto L, Pace A, Asquino A, Valentino F, Sabatini A, Petti M,
et al. Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study. Cancers. 2025; 17(6):922.
https://doi.org/10.3390/cancers17060922
Chicago/Turabian Style
Sibilio, Pasquale, Ilaria Grazia Zizzari, Alain Gelibter, Marco Siringo, Lucrezia Tuosto, Angelica Pace, Angela Asquino, Flavio Valentino, Arianna Sabatini, Manuela Petti,
and et al. 2025. "Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study" Cancers 17, no. 6: 922.
https://doi.org/10.3390/cancers17060922
APA Style
Sibilio, P., Zizzari, I. G., Gelibter, A., Siringo, M., Tuosto, L., Pace, A., Asquino, A., Valentino, F., Sabatini, A., Petti, M., Bellati, F., Santini, D., Nuti, M., Farina, L., Rughetti, A., & Napoletano, C.
(2025). Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study. Cancers, 17(6), 922.
https://doi.org/10.3390/cancers17060922
